BFRG
Bullfrog AI Holdings, Inc.
Price Chart
Latest Quote
$0.70
| Previous Close | $0.69 |
| Open | $0.67 |
| Day High | $0.75 |
| Day Low | $0.66 |
| Volume | 289,603 |
Stock Information
| Shares Outstanding | 18.54M |
| Total Debt | $134K |
| Cash Equivalents | $5.08M |
| Revenue | $117K |
| Net Income | $-6.07M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $12.93M |
| EPS (TTM) | $-0.54 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.91M |
| Sales | $117K |
| Income | $-6.07M |
| Book/sh | $0.19 |
| Cash/sh | $0.27 |
| Employees | 9 |
Financial Ratios
| Quick Ratio | 7.79 |
| Current Ratio | 8.15 |
| Debt/Eq | 2.74 |
Returns & Margins
| ROA | -79.91% |
| ROE | -149.35% |
| Gross Margin | 18.76% |
| Operating Margin | -5273.54% |
Ownership
| Insider Ownership | 13.16% |
| Institutional Ownership | 2.87% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 110.85 |
| P/B | 3.73 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.69 |
| SMA50 | $0.75 |
| SMA200 | $0.93 |
| RSI | 47.76 |
| ATR | 0.0722 |
| Shares Float | 16.10M |
| Short Float | 3.47% |
| Short Ratio | 1.60 |
| Rel Volume | 0.97 |
Performance History
| Week | +2.95% |
| Month | +18.71% |
| Quarter | +14.80% |
| 6 Months | -33.52% |
| YTD | -20.68% |
| Year | -59.89% |
| 3 Years | -82.37% |
| 10 Years | -89.26% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.70 | 309,200 |
| 2026-06-16 | $0.69 | 214,400 |
| 2026-06-15 | $0.64 | 173,800 |
| 2026-06-12 | $0.62 | 380,100 |
| 2026-06-11 | $0.63 | 625,100 |
| 2026-06-10 | $0.68 | 141,700 |
| 2026-06-09 | $0.67 | 171,800 |
| 2026-06-08 | $0.67 | 199,300 |
| 2026-06-05 | $0.67 | 316,200 |
| 2026-06-04 | $0.77 | 201,200 |
| 2026-06-03 | $0.73 | 242,700 |
| 2026-06-02 | $0.77 | 262,800 |
| 2026-06-01 | $0.70 | 332,100 |
| 2026-05-29 | $0.76 | 635,600 |
| 2026-05-28 | $0.72 | 391,800 |
| 2026-05-27 | $0.67 | 405,600 |
| 2026-05-26 | $0.71 | 508,600 |
| 2026-05-22 | $0.65 | 242,500 |
| 2026-05-21 | $0.67 | 205,400 |
| 2026-05-20 | $0.66 | 395,500 |
| 2026-05-19 | $0.62 | 375,900 |
| 2026-05-18 | $0.59 | 314,200 |
About Bullfrog AI Holdings, Inc.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $94,778 | $0 | $5,200 | $800 |
| Cost Of Revenue | $94,778 | $0 | $5,200 | $800 |
| Total Revenue | $116,670 | $0 | $65,000 | $10,000 |
| Operating Revenue | $116,670 | $0 | $65,000 | $10,000 |
| Expenses | ||||
| Interest Expense | $5,629 | $18,158 | $79,089 | $347,145 |
| Total Expenses | $6,711,306 | $7,236,383 | $5,432,524 | $2,465,801 |
| Net Non Operating Interest Income Expense | $96,568 | $242,736 | $104,614 | $-346,686 |
| Interest Expense Non Operating | $5,629 | $18,158 | $79,089 | $347,145 |
| Operating Expense | $6,616,528 | $7,236,383 | $5,427,324 | $2,465,001 |
| General And Administrative Expense | $4,816,790 | $5,013,118 | $3,994,710 | $1,855,731 |
| Other Income Expense | - | - | $-92,959 | $459 |
| Other Non Operating Income Expenses | - | - | $-92,959 | $459 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Net Interest Income | $96,568 | $242,736 | $104,614 | $-346,686 |
| Interest Income | $102,197 | $260,894 | $183,703 | $459 |
| Normalized Income | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Net Income From Continuing And Discontinued Operation | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Total Operating Income As Reported | $-6,594,636 | $-7,236,383 | $-5,367,524 | $-2,455,801 |
| Net Income Common Stockholders | $-6,498,068 | $-7,038,632 | $-5,355,869 | $-2,802,487 |
| Net Income | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Net Income Including Noncontrolling Interests | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Net Income Continuous Operations | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Pretax Income | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Interest Income Non Operating | $102,197 | $260,894 | $183,703 | $459 |
| Operating Income | $-6,594,636 | $-7,236,383 | $-5,367,524 | $-2,455,801 |
| Gross Profit | $21,892 | $0 | $59,800 | $9,200 |
| Special Income Charges | - | - | $-92,959 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.63 | $-0.85 | $-0.89 | $-0.49 |
| Basic EPS | $-0.63 | $-0.85 | $-0.89 | $-0.49 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,490,714 | $-6,973,765 | $-5,275,055 | $-2,454,297 |
| Reconciled Depreciation | $1,725 | $1,724 | $1,725 | $1,045 |
| EBITDA (Bullshit earnings) | $-6,490,714 | $-6,973,765 | $-5,275,055 | $-2,454,297 |
| EBIT | $-6,492,439 | $-6,975,489 | $-5,276,780 | $-2,455,342 |
| Diluted Average Shares | $10,337,073 | $8,245,353 | $6,049,819 | $5,671,881 |
| Basic Average Shares | $10,337,073 | $8,245,353 | $6,049,819 | $5,671,881 |
| Diluted NI Availto Com Stockholders | $-6,498,068 | $-7,038,632 | $-5,355,869 | $-2,802,487 |
| Research And Development | $1,799,738 | $2,223,265 | $1,432,614 | $609,270 |
| Selling General And Administration | $4,816,790 | $5,013,118 | $3,994,710 | $1,855,731 |
| Other Gand A | $4,816,790 | $5,013,118 | $3,994,710 | $1,855,731 |
| Preferred Stock Dividends | - | $44,985 | - | - |
| Total Unusual Items | - | - | $-92,959 | $0 |
| Total Unusual Items Excluding Goodwill | - | - | $-92,959 | $0 |
| Other Special Charges | - | - | $92,959 | - |
| Salaries And Wages | - | - | - | $547,849 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,136,329 | $4,963,740 | $2,592,236 | $-3,057,352 |
| Total Assets | $2,808,351 | $5,551,830 | $2,776,586 | $80,369 |
| Total Non Current Assets | $224,195 | $4,250 | $5,974 | $7,699 |
| Other Non Current Assets | $105,000 | - | - | - |
| Investmentin Financial Assets | $116,670 | $0 | - | - |
| Current Assets | $2,584,156 | $5,547,580 | $2,770,612 | $72,670 |
| Prepaid Assets | $400,451 | $111,597 | $145,882 | $15,000 |
| Cash Cash Equivalents And Short Term Investments | $2,183,705 | $5,435,983 | $2,624,730 | $57,670 |
| Cash And Cash Equivalents | $2,183,705 | $5,435,983 | $2,624,730 | $57,670 |
| Cash Financial | - | - | - | $57,670 |
| Debt | ||||
| Net Debt | - | - | - | $1,521,070 |
| Total Debt | - | - | - | $1,578,740 |
| Current Debt And Capital Lease Obligation | - | - | - | $1,578,740 |
| Current Debt | - | - | - | $1,578,740 |
| Other Current Borrowings | - | - | - | $1,578,740 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $672,022 | $588,090 | $184,350 | $3,137,721 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $672,022 | $588,090 | $184,350 | $3,137,721 |
| Payables And Accrued Expenses | $672,022 | $588,090 | $184,350 | $1,526,981 |
| Payables | $168,151 | $435,934 | $103,656 | $543,993 |
| Accounts Payable | $168,151 | $435,934 | $103,656 | $543,993 |
| Current Deferred Liabilities | - | - | $0 | $32,000 |
| Current Notes Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $2,136,328 | $4,963,739 | $2,592,235 | $-3,057,353 |
| Preferred Stock Equity | $1 | $1 | $1 | $1 |
| Total Equity Gross Minority Interest | $2,136,329 | $4,963,740 | $2,592,236 | $-3,057,352 |
| Stockholders Equity | $2,136,329 | $4,963,740 | $2,592,236 | $-3,057,352 |
| Retained Earnings | $-23,291,624 | $-16,793,556 | $-9,754,924 | $-4,399,055 |
| Other | ||||
| Ordinary Shares Number | $11,418,183 | $9,113,139 | $6,094,644 | $5,671,881 |
| Share Issued | $11,418,183 | $9,113,139 | $6,094,644 | $5,671,881 |
| Tangible Book Value | $2,136,328 | $4,963,739 | $2,592,235 | $-3,057,353 |
| Invested Capital | $2,136,328 | $4,963,739 | $2,592,235 | $-1,478,613 |
| Working Capital | $1,912,134 | $4,959,490 | $2,586,262 | $-3,065,051 |
| Total Capitalization | $2,136,329 | $4,963,740 | $2,592,236 | $-3,057,352 |
| Additional Paid In Capital | $25,427,838 | $21,757,204 | $12,347,098 | $1,341,662 |
| Capital Stock | $115 | $92 | $62 | $41 |
| Common Stock | $114 | $91 | $61 | $40 |
| Preferred Stock | $1 | $1 | $1 | $1 |
| Current Accrued Expenses | $503,871 | $152,156 | $80,694 | $982,988 |
| Investments And Advances | $116,670 | $0 | - | - |
| Available For Sale Securities | $116,670 | - | - | - |
| Net PPE | $2,525 | $4,250 | $5,974 | $7,699 |
| Accumulated Depreciation | $-6,219 | $-4,494 | $-2,770 | $-1,045 |
| Gross PPE | $8,744 | $8,744 | $8,744 | $8,744 |
| Other Properties | $8,744 | $8,744 | $8,744 | $8,744 |
| Current Deferred Revenue | - | - | $0 | $32,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,522,265 | $-5,610,249 | $-6,001,299 | $-919,634 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,522,265 | $-5,610,249 | $-6,001,299 | $-910,890 |
| Cash Flow From Continuing Operating Activities | $-5,522,265 | $-5,610,249 | $-6,001,299 | $-910,890 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $0 | $-8,744 |
| Cash Flow From Continuing Investing Activities | - | $0 | $0 | $-8,744 |
| Capital Expenditure | - | - | - | $-8,744 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,467,533 | $8,315,686 | $7,293,651 | $0 |
| Financing Cash Flow | $2,374,987 | $8,421,502 | $8,568,359 | $967,290 |
| Cash Flow From Continuing Financing Activities | $2,374,987 | $8,421,502 | $8,568,359 | $967,290 |
| Net Other Financing Charges | $-92,546 | - | - | - |
| Net Common Stock Issuance | $2,467,533 | $8,315,686 | $7,293,651 | $0 |
| Common Stock Issuance | $2,467,533 | $8,315,686 | $7,293,651 | $0 |
| Other | ||||
| Repayment Of Debt | $-181,797 | $-561,885 | $-1,017,484 | $-49,000 |
| Issuance Of Debt | $181,797 | $561,885 | $797,534 | $1,016,290 |
| Interest Paid Supplemental Data | $5,629 | $18,158 | $93,916 | $5,757 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,288,705 | $5,435,983 | $2,624,730 | $57,670 |
| Beginning Cash Position | $5,435,983 | $2,624,730 | $57,670 | $10,014 |
| Changes In Cash | $-3,147,278 | $2,811,253 | $2,567,060 | $47,656 |
| Proceeds From Stock Option Exercised | $0 | $105,816 | $1,494,658 | $0 |
| Net Issuance Payments Of Debt | $0 | $0 | $-219,950 | $967,290 |
| Net Short Term Debt Issuance | $0 | $0 | $0 | $967,290 |
| Short Term Debt Payments | $-181,797 | $-561,885 | $-697,534 | $-49,000 |
| Short Term Debt Issuance | $181,797 | $561,885 | $697,534 | $1,016,290 |
| Change In Working Capital | $80,117 | $438,025 | $-1,441,647 | $1,136,922 |
| Change In Payables And Accrued Expense | $68,932 | $403,740 | $-1,278,765 | $1,129,922 |
| Change In Accrued Expense | $336,715 | $71,462 | $-838,428 | $654,523 |
| Change In Payable | $-267,783 | $332,278 | $-440,337 | $475,399 |
| Change In Account Payable | $-267,783 | $332,278 | $-440,337 | $475,399 |
| Change In Prepaid Assets | $11,185 | $34,285 | $-130,882 | $-15,000 |
| Other Non Cash Items | $-116,670 | - | $162,959 | $413,478 |
| Stock Based Compensation | $1,010,631 | $943,649 | $631,533 | $340,152 |
| Depreciation Amortization Depletion | $1,725 | $1,724 | $1,725 | $1,045 |
| Depreciation And Amortization | $1,725 | $1,724 | $1,725 | $1,045 |
| Depreciation | $1,725 | $1,724 | $1,725 | $1,045 |
| Net Income From Continuing Operations | $-6,498,068 | $-6,993,647 | $-5,355,869 | $-2,802,487 |
| Net Long Term Debt Issuance | - | $0 | $-219,950 | $0 |
| Long Term Debt Payments | - | $0 | $-319,950 | $0 |
| Long Term Debt Issuance | - | $0 | $100,000 | $0 |
| Net PPE Purchase And Sale | - | $0 | $0 | $-8,744 |
| Purchase Of PPE | - | $0 | $0 | $-8,744 |
| Change In Other Working Capital | - | - | $-32,000 | $22,000 |